Onkolyze is a company that develops artificial intelligence (AI) software that can diagnose medical conditions. It was founded in 2018 by Rory Wilding and Vivek Sheraton. The company aims to aid radiologists in diagnosing a patient’s medical conditions. Onkolyze is based in Singapore.
Onkolyze develops software that can be used in most picture archiving and communication system (PACS) that are in use by healthcare professionals. The company’s most recently developed product is a diagnostic assistant for breast cancer detection. Using Onkolyze’s software, medical professionals can create individualized treatment plans for patients according to recent scientific research. Onkolyze's platform should enable oncologists to predict how chemotherapy will shrink specific patient's tumors before treatment.
The possible optimization of treatment offers improved patient outcomes and promises to save the healthcare ecosystem time and money.
Since its founding year, the company has received funding from Entrepreneur First during its seed-stage round.
Documentaries, videos and podcasts
Onkolyze - EFSG3 Investor Day
July 24, 2018